RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the ...

IT’S AN UNLIKELY PAIRING: swimming with sharks in the Caribbean Sea on Monday, then receiving stem cell injections on Tuesday ...

RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the enrollment of the first patient in its Phase 1b clinical study evaluating ...

Use of an aragonite-based scaffold for the treatment of chondral or osteochondral defects of the knee had superior outcomes compared with debridement or microfracture at 4-year follow-up, according to ...

Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ETCompany ParticipantsDave Crawford - Investor RelationsRob Claypoole ...